The Journal of Organic Chemistry
Article
ppm; HRMS (m/z) = [C16H12NO4I + H]+ calcd 409.9884, found
409.9888.
chromatography (1:2 PhMe/Pet. Sp.) afforded the title compound
as a pale yellow oil (304 mg, 85%): 1H NMR (400 MHz, CDCl3) δ =
7.46−7.49 (m, 2H), 7.32−7.38 (m, 3H), 2.53 (t, J = 7.4 Hz, 2H), 2.11
(s, 3H), 1.55−1.63 (m, 2H), 1.32−1.38 (m, 4H), 0.92 (t, J = 7.4 Hz,
3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.3, 146.3, 137.6,
129.8, 128.9, 127.9, 96.9, 38.1, 30.7, 28.6, 22.4, 20.6, 14.0 ppm; HRMS
(m/z) = [C15H19O2I + Na]+ calcd 381.0322, found 381.0317.
(E)-2-Iodo-2-(4-cyanophenyl)-1-phenylvinyl acetate (2c). General
procedure 1 was followed using 4-(phenylethynyl)benzonitrile.
Purification by column chromatography (1:1 PhMe/Pet. Sp. →
100% PhMe) afforded the title compound as a pale yellow solid (339
1
mg, 87%): mp = 132.0−133.7 °C; H NMR (400 MHz, CDCl3) δ =
7.61−7.66 (m, 4H), 7.54 (d, J = 8.6 Hz, 2H), 7.40−7.44 (m, 3H), 1.86
(s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 148.8, 145.4,
136.4, 132.1, 129.8, 129.5, 128.2, 118.4, 112.0, 85.7, 20.4 ppm; HRMS
(m/z) = [C17H12NO2I + H]+ calcd 389.9985, found 389.9987.
(E)-2-Iodo-2-phenyl-1-(p-tolyl)vinyl acetate (2d).15 General pro-
cedure 1 was followed using 1-methyl-4-(phenylethynyl)benzene.
Purification by column chromatography (1:1 PhMe/Pet. Sp.) afforded
the title compound as a white solid (321 mg, 85%): mp = 78.5−81.0
°C; 1H NMR (400 MHz, CDCl3) δ = 7.46 (d, J = 8.1 Hz, 2H), 7.33−
7.35 (m, 2H), 7.23−7.28 (m, 2H), 7.18−7.20 (m, 1H), 7.11 (d, J = 7.9
Hz, 2H), 2.29 (s, 3H), 1.72 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3) δ = 168.7, 147.4, 140.9, 139.4, 134.3, 129.5, 128.8, 128.5,
128.30, 128.26, 88.6, 21.5, 20.5 ppm; HRMS (m/z) = [C17H15O2I +
H]+ calcd 379.0189, found 379.0184.
General Procedure 2 for the Iodo-acyloxylation of Alkynes.
In a 100 mL RBF was combined iodobenzene diacetate (1.0 mmol),
the carboxylic acid (2.0 mmol) and chlorobenzene (20 mL). The
solution was then stirred on the rotary evaporator for 10 min at 50 °C,
after which time the solvent was slowly evaporated over 30 min under
reduced pressure. The resultant iodobenzene dicarboxylate was further
dried on the high vacuum for an additional 30 min and then dissolved
in DCE (5 mL) containing 4Å molecular sieves (∼1.0 g), and I2 (1.0
mmol) added. After stirring for 10 min, diphenylacetylene (1.2 mmol)
was added in one portion, and the resultant solution stirred at rt for 4
h. After this time, the molecular sieves were filtered off, and the
reaction quenched by the addition of Na2S2O3 (10% w/w aqueous, 10
mL). The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The
combined organic fractions were dried over MgSO4 and filtered, and
the solvent evaporated. The product was purified by either
recrystallization or flash column chromatography as stated.
(E)-4-Iodohex-3-en-3-yl acetate (2e).7 General procedure 1 was
followed using 3-hexyne. Purification by column chromatography
(1:19 EtOAc/Pet. Sp.) afforded the title compound as a pale yellow oil
(217 mg, 81%): 1H NMR (400 MHz, CDCl3) δ = 2.48 (q, J = 7.5 Hz,
2H), 2.26 (q, J = 7.4 Hz, 2H), 2.10 (s, 3H), 0.94 (t, J = 7.5 Hz, 3H),
0.93 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.4,
148.7, 96.1, 31.1, 29.8, 20.4, 14.0, 10.9 ppm; HRMS (m/z) =
[C8H13O2I]+ calcd 267.9955, found 267.9958.
(E)-2-Iodo-1,2-diphenylvinyl benzoate (2n). General procedure 2
was followed using benzoic acid and diphenylacetylene. Purification by
recrystallization from ethanol afforded the title compound as a white
1
solid (358 mg, 84%): mp = 106.2−110.4 °C; H NMR (400 MHz,
CDCl3) δ = 7.82 (dd, J = 1.3 and 8.4 Hz, 2H), 7.75 (dd, J = 1.4 and 8.2
Hz, 2H), 7.48−7.53 (m, 3H), 7.40−7.44 (m, 3H), 7.33−7.38 (m, 2H),
7.26−7.30 (m, 2H), 7.19 (dt, J = 1.3 and 8.7 Hz, 1H) ppm; 13C NMR
(100 MHz, CDCl3) δ = 164.3, 147.3, 140.6, 137.1, 133.5, 129.9, 129.8,
129.4, 128.9, 128.6, 128.4, 128.3, 128.2, 128.1, 89.3 ppm; HRMS (m/
z) = [C21H15O2I + H]+ calcd 427.0189, found 427.0182.
(Z)-2-Iodo-1-(4-methoxyphenyl)-2-phenylvinyl acetate (2f).9
General procedure 1 was followed using 1-methoxy-4-(phenyl-
ethynyl)benzene. Purification by column chromatography (1:1
PhMe/Pet. Sp. → 100% PhMe) afforded the title compound as a
1
pale yellow solid (367 mg, 93%): mp = 125.6−128.3 °C; H NMR
(E)-2-Iodo-1,2-diphenylvinyl 3-(trifluoromethyl)benzoate (2o).
General procedure 2 was followed using 3-trifluoromethylbenzoic
acid and diphenylacetylene. Purification by column chromatography
(1:1 PhMe/Pet. Sp.) afforded the title compound as a yellow solid
(351 mg, 71%): mp = 120.2−121.9 °C; 1H NMR (400 MHz, CDCl3)
δ = 8.04 (s, 1H), 7.97 (d, J = 7.8 Hz, 1H), 7.72−7.76 (m, 3H), 7.37−
7.50 (m, 6H), 7.29 (t, J = 7.3 Hz, 2H), 7.19 (dt, J = 1.3 and 6.7 Hz,
1H) ppm; 13C NMR (100 MHz, CDCl3) δ = 163.0, 146.9, 140.4,
136.7, 133.0, 129.9 (q, J = 3.6 Hz), 129.5, 129.1, 128.5, 128.4, 128.3,
128.2, 126.7 (q, J = 3.8 Hz), 89.6 ppm; 19F NMR (400 MHz, CDCl3)
δ = −62.90 ppm; HRMS (m/z) = [C22H14F3O2I + H]+ calcd
495.0063, found 495.0050.
(400 MHz, CDCl3) δ = 7.27−7.30 (m, 2H), 7.17−7.23 (m, 3H), 7.08
(d, J = 9.0 Hz, 2H), 6.64 (d, J = 9.0 Hz, 2H), 3.72 (s, 3H), 2.29 (s,
3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.0, 159.6, 149.9,
140.8, 130.21, 130.17, 128.4, 128.1, 125.8, 113.5, 89.9, 55.2, 21.4 ppm;
HRMS (m/z) = [C17H15O3I + Na]+ calcd 416.9958, found 416.9959.
(Z)-1-(4-((Ethoxycarbonyl)amino)phenyl)-2-iodo-2-phenylvinyl
acetate (2g). General procedure 1 was followed using 1-
(ethoxycarbonyl)amino-4-(phenylethynyl)benzene. Purification by
recrystallization from ethanol afforded the title compound as a pale
1
yellow solid (320 mg, 71%): mp = 161.4−164.6 °C; H NMR (400
MHz, CDCl3) δ = 7.18−7.22 (m, 2H), 7.10−7.16 (m, 3H), 7.07 (d, J
= 8.8 Hz, 2H), 6.99 (dt, J = 2.2 and 8.8 Hz, 2H), 6.46 (brs, 1H), 4.12
(q, J = 7.1 Hz, 2H), 2.22 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H) ppm; 13C
NMR (100 MHz, CDCl3) δ = 168.0, 153.2, 149.6, 140.6, 138.2, 130.2,
129.6, 128.4, 128.3, 117.7, 90.7, 61.4, 21.4, 14.5 ppm; HRMS (m/z) =
[C19H18NO4I + H]+ calcd 452.0353, found 452.0358.
(E)-2-Iodo-1,2-diphenylvinyl 3,4-dimethylbenzoate (2p). General
procedure 2 was followed using 3,4-dimethylbenzoic acid and
diphenylacetylene. Purification by column chromatography (1:1
PhMe/Pet. Sp.) afforded the title compound yellow oil that solidified
1
upon standing (341 mg, 75%): H NMR (400 MHz, CDCl3) δ =
(E)-2-Iodo-1-phenylpent-1-en-1-yl acetate (2h). General proce-
dure 1 was followed using 1-phenylpentyne. Purification by column
chromatography (1:2 PhMe/Pet. Sp.) afforded the title compound as a
7.64−7.67 (m, 2H), 7.51 (s, 1H), 7.46 (dd, J = 1.7 and 7.9 Hz, 1H),
7.40−7.43 (m, 2H), 7.28−7.32 (m, 3H), 7.17−7.21 (m, 2H), 7.09 (tt,
J = 1.3, 6.7, and 8.2 Hz, 1H), 7.01 (d, J = 7.8 Hz, 1H), 2.17 (s, 3H),
2.14 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 164.6, 147.4,
143.0, 140.7, 137.3, 136.8, 131.0, 129.75, 129.66, 129.3, 128.7, 128.23,
128.17, 128.0, 127.5, 126.4, 89.1, 20.0, 19.6 ppm; HRMS (m/z) =
[C23H19O2I + H]+ calcd 455.0502, found 455.0500.
1
pale yellow oil (258 mg, 78%): H NMR (400 MHz, CDCl3) δ =
7.38−7.40 (m, 2H), 7.21−7.26 (m, 3H), 2.43 (t, J = 7.4 Hz, 2H), 2.00
(s, 3H), 1.52 (sext, J = 7.4 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H) ppm; 13C
NMR (100 MHz, CDCl3) δ = 168.3, 146.6, 137.6, 129.8, 128.9, 127.9,
96.7, 40.0, 22.4, 20.6, 13.2 ppm; HRMS (m/z) = [C13H15O2I + Na]+
calcd 353.0009, found 353.0008.
(E)-2-Iodo-1-phenylhex-1-en-1-yl acetate (2i). General procedure
1 was followed using 1-phenylhexyne. Purification by column
chromatography (1:2 PhMe/Pet. Sp.) afforded the title compound
as a pale yellow oil (289 mg, 84%): 1H NMR (400 MHz, CDCl3) δ =
7.46−7.49 (m, 2H), 7.31−7.37 (m, 3H), 2.54 (t, J = 7.4 Hz, 2H), 2.11
(s, 3H), 1.53−1.61 (m, 2H), 1.33−1.43 (sext., J = 7.5 Hz, 2H), 0.96 (t,
J = 7.4 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.3, 146.3,
137.6, 129.8, 128.9, 127.9, 96.9, 37.8, 31.1, 21.7, 20.6, 13.9 ppm;
HRMS (m/z) = [C14H17O2I + Na]+ calcd 367.0165, found 367.0161.
(E)-2-Iodo-1-phenylhept-1-en-1-yl acetate (2j). General procedure
1 was followed using 1-phenylheptyne. Purification by column
(E)-2-Iodo-1,2-diphenylvinyl 3-phenylpropanoate (2q). General
procedure 2 was followed using 3-phenylpropanoic acid and
diphenylacetylene. Purification by column chromatography (1:1
PhMe/Pet. Sp.) afforded the title compound as a clear oil (350 mg,
1
77%): H NMR (400 MHz, CDCl3) δ = 7.52−7.55 (m, 2H), 7.31−
7.34 (m, 4H), 7.20−7.25 (m, 2H), 7.17−7.19 (m, 2H), 7.07−7.12
(3H), 6.91−6.93 (m, 2H), 2.57 (t, J = 7.5 Hz, 2H), 2.31−2.35 (m,
2H) ppm; 13C NMR (100 MHz, CDCl3) δ = 170.5, 147.2, 140.7,
139.9, 137.0, 129.7, 129.3, 128.54, 128.48, 128.4, 128.3, 128.14,
128.10, 126.3, 88.9, 35.2, 30.3 ppm; HRMS (m/z) = [C23H19O2I +
H]+ calcd 455.0502, found 455.0495.
(E)-2-Iodo-1,2-diphenylvinyl 2-((1S,4R)-bicyclo[2.2.1]heptan-2-
yl)acetate (2r). General procedure 2 was followed using 2-
4416
J. Org. Chem. 2015, 80, 4412−4418